Replies to post #47498 on Ayala Pharmaceuticals Inc (fka ADXS)

[DewDiligence]

Re: ADXS-NEO in CRC

…for those who didn't look at the slides on the corporate presentation, it explains why we are targeting Colon Cancer, Metastatic Squamous Histology Head and Neck Cancer, and Metastatic Non-Small Cell Lung Cancer for NEO.

There seems to be a difference of opinion on whether colorectal cancer (CRC) is high-mutation or low-mutation. Please see the discussion in #msg-137210916.